Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249. https://doi.org/10.3322/caac.21660

Article  PubMed  Google Scholar 

Ajani JA, D’Amico TA, Bentrem DJ et al (2019) Esophageal and esophagogastric junction cancers, version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 17:855–883. https://doi.org/10.6004/jnccn.2019.0033

Article  CAS  PubMed  Google Scholar 

Cooper JS, Guo MD, Herskovic A et al (1999) Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85–01) Radiation Therapy Oncology Group. JAMA 281:1623–1627

Article  CAS  PubMed  Google Scholar 

Kato K, Muro K, Minashi K et al (2011) Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906). Int J Radiat Oncol Biol Phys 81:684–690. https://doi.org/10.1016/j.ijrobp.2010.06.033

Article  CAS  PubMed  Google Scholar 

Minsky BD, Pajak TF, Ginsberg RJ et al (2002) INT 0123 (Radiation Therapy Oncology Group 94–05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 20(5):1167–1174

Article  CAS  PubMed  Google Scholar 

Ohtsu A, Boku N, Muro K et al (1999) Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol 17:2915–2921

Article  CAS  PubMed  Google Scholar 

Wang WP, He SL, Yang YS, Chen LQ (2018)Strategies of nodal staging of the TNM system for esophageal cancer. Ann Transl Med 6:77. https://doi.org/10.21037/atm.2017.12.17

Gertler R, Stein HJ, Langer R et al (2011) Long-term outcome of 2920 patients with cancers of the esophagus and esophagogastric junction: evaluation of the New Union Internationale Contre le Cancer/American Joint Cancer Committee staging system. Ann Surg 253:689–698. https://doi.org/10.1097/SLA.0b013e31821111b5

Article  PubMed  Google Scholar 

Hamai Y, Hihara J, Emi M et al (2017) Effects of neoadjuvant chemoradiotherapy on pathological TNM stage and their prognostic significance for surgically-treated esophageal squamous cell carcinoma. Anticancer Res 37:5639–5646

CAS  PubMed  Google Scholar 

Oweira H, Schmidt J, Mehrabi A et al (2018) Validation of the eighth clinical American Joint Committee on Cancer stage grouping for esophageal cancer. Future Oncol 14:65–75. https://doi.org/10.2217/fon-2017-0376

Article  CAS  PubMed  Google Scholar 

Zeng C, Zhai T, Chen J et al (2021) Imaging biomarkers of contrast-enhanced computed tomography predict survival in oesophageal cancer after definitive concurrent chemoradiotherapy. Radiat Oncol 16:8. https://doi.org/10.1186/s13014-020-01699-w

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luo H-S, Chen Y-Y, Huang W-Z et al (2021) Development and validation of a radiomics-based model to predict local progression-free survival after chemo-radiotherapy in patients with esophageal squamous cell cancer. Radiat Oncol 16:201. https://doi.org/10.1186/s13014-021-01925-z

Article  PubMed  PubMed Central  Google Scholar 

Hu G, Liu G, Ma J-Y, Hu R-J (2018) Lymphocyte-to-monocyte ratio in esophageal squamous cell carcinoma prognosis. Clin Chim Acta 486:44–48. https://doi.org/10.1016/j.cca.2018.07.029

Article  CAS  PubMed  Google Scholar 

Chen C-J, Lee C-T, Tsai Y-N et al (2022) Prognostic significance of systemic inflammatory response markers in patients with superficial esophageal squamous cell carcinomas. Sci Rep 12:18241. https://doi.org/10.1038/s41598-022-21974-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lambin P, Rios-Velazquez E, Leijenaar R et al (2012) Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer 48:441–446. https://doi.org/10.1016/j.ejca.2011.11.036

Article  PubMed  PubMed Central  Google Scholar 

Cui Y, Li Z, Xiang M, Han D, Yin Y, Ma C (2022) Machine learning models predict overall survival and progression free survival of non-surgical esophageal cancer patients with chemoradiotherapy based on CT image radiomics signatures. Radiat Oncol 17:212. https://doi.org/10.1186/s13014-022-02186-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen L, Zeng H, Yang J et al (2018) Survival and prognostic analysis of preoperative inflammatory markers in patients undergoing surgical resection for laryngeal squamous cell carcinoma. BMC Cancer 18:816. https://doi.org/10.1186/s12885-018-4730-x

Article  PubMed  PubMed Central  Google Scholar 

Cong R, Kong F, Ma J, Li Q, Wu Q, Ma X (2020) Combination of preoperative neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and monocyte-lymphocyte ratio: a superior prognostic factor of endometrial cancer. BMC Cancer 20:464. https://doi.org/10.1186/s12885-020-06953-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Y, Han N, Zeng X et al (2022) Impact of platelets to lymphocytes ratio and lymphocytes during radical concurrent radiotherapy and chemotherapy on patients with nonmetastatic esophageal squamous cell carcinoma. J Oncol 2022:3412349. https://doi.org/10.1155/2022/3412349

Article  PubMed  PubMed Central  Google Scholar 

Rice TW, Gress DM, Patil DT, Hofstetter WL, Kelsen DP, Blackstone EH (2017) Cancer of the esophagus and esophagogastric junction-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin 67:304-317. https://doi.org/10.3322/caac.21399

Endrikat J, Chernova J, Gerlinger C et al (2022) Risk of hypersensitivity reactions to iopromide in children and elderly: an analysis of 132,850 patients from 4 observational studies and pharmacovigilance covering >288 million administrations. Invest Radiol 57:318–326. https://doi.org/10.1097/RLI.0000000000000840

Article  CAS  PubMed  Google Scholar 

Camp RL, Dolled-Filhart M, Rimm DL (2004) X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 10:7252–7259

Article  CAS  PubMed  Google Scholar 

Bi WL, Hosny A, Schabath MB et al (2019) Artificial intelligence in cancer imaging: clinical challenges and applications. CA Cancer J Clin 69:127–157. https://doi.org/10.3322/caac.21552

Article  PubMed  PubMed Central  Google Scholar 

Lambin P, Leijenaar RTH, Deist TM et al (2017) Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol 14:749–762. https://doi.org/10.1038/nrclinonc.2017.141

Article  PubMed  Google Scholar 

Ji G-W, Zhang Y-D, Zhang H et al (2019) Biliary tract cancer at CT: a radiomics-based model to predict lymph node metastasis and survival outcomes. Radiology 290:90–98. https://doi.org/10.1148/radiol.2018181408

Article  PubMed  Google Scholar 

Gong J, Zhang W, Huang W et al (2022) CT-based radiomics nomogram may predict local recurrence-free survival in esophageal cancer patients receiving definitive chemoradiation or radiotherapy: a multicenter study. Radiother Oncol 174. https://doi.org/10.1016/j.radonc.2022.06.010

Tang S, Ou J, Liu J et al (2021) Application of contrast-enhanced CT radiomics in prediction of early recurrence of locally advanced oesophageal squamous cell carcinoma after trimodal therapy. Cancer Imaging 21:38. https://doi.org/10.1186/s40644-021-00407-5

Article  PubMed  PubMed Central  Google Scholar 

Crusz SM, Balkwill FR (2015) Inflammation and cancer: advances and new agents. Nat Rev Clin Oncol 12:584–596. https://doi.org/10.1038/nrclinonc.2015.105

Article  CAS  PubMed  Google Scholar 

Nishijima TF, Muss HB, Shachar SS, Tamura K, Takamatsu Y (2015) Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: a systematic review and meta-analysis. Cancer Treat Rev 41:971–978. https://doi.org/10.1016/j.ctrv.2015.10.003

Article  PubMed  Google Scholar 

Wang Y, Huang D, Xu W-Y, Wang Y-W, Che G-W (2019) Prognostic value of pretreatment lymphocyte-to-monocyte ratio in non-small cell lung cancer: a meta-analysis. Oncol Res Treat 42:523–531. https://doi.org/10.1159/000501726

Article  PubMed  Google Scholar 

Tan D, Fu Y, Tong W, Li F (2018) Prognostic significance of lymphocyte to monocyte ratio in colorectal cancer: a meta-analysis. Int J Surg 55:128–138. https://doi.org/10.1016/j.ijsu.2018.05.030

Article  PubMed  Google Scholar 

Yin Y, Zhang Y, Li L, Zhang S, Liu N, Yuan S (2021) Prognostic value of pretreatment lymphocyte-to-monocyte ratio and development of a nomogram in breast cancer patients. Front Oncol 11:650980. https://doi.org/10.3389/fonc.2021.650980

Article  PubMed  PubMed Central  Google Scholar 

Tang F, Dai P, Wei Q et al (2021) The neutrophil-to-monocyte ratio and platelet-to-white blood cell ratio represent novel prognostic markers in patients with pancreatic cancer. Gastroenterol Res Pract 2021:6693028. https://doi.org/10.1155/2021/6693028

Article  PubMed  PubMed Central  Google Scholar 

Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140:883–899. https://doi.org/10.1016/j.cell.2010.01.025

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bausch D, Pausch T, Krauss T et al (2011) Neutrophil granulocyte derived MMP-9 is a VEGF independent functional component of the angiogenic switch in pancreatic ductal adenocarcinoma. Angiogenesis 14:235–243. https://doi.org/10.1007/s10456-011-9207-3

Article  CAS  PubMed  PubMed Central